Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-22

Clinical Trial Update: Cefazolin Versus Antistaphylococcal Penicillins for Methicillin Susceptible Staphylococcus Aureus Bacteremia

View source ↗

Summary

A clinical trial comparing cefazolin with antistaphylococcal penicillins for methicillin-susceptible Staphylococcus aureus bacteremia; the study is currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CEFAZOLIN (cefazolin sodium)
  • Nafcillin (nafcillin)
  • Oxacillin (oxacillin)

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Bacteriemia, Methicillin Susceptible Staphylococcus Aureus (MSSA) Infection | Status: ACTIVE_NOT_RECRUITING